1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–573. [PMC free article] [PubMed] [Google Scholar]
2. Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792. [PubMed] [Google Scholar]
3. [Accessed September 19, 2010];Physician Quality Reporting Initiative (PQRI) //www.cms.gov/PQRI/
4. Cronin KA, Yu B, Krapcho M, et al. Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005;16(6):701–712. [PubMed] [Google Scholar]
5. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med. 2007;146(7):516–526. [PubMed] [Google Scholar]
6. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 2005;293(10):1245–1256. [PMC free article] [PubMed] [Google Scholar]
7. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659–669. [PMC free article] [PubMed] [Google Scholar]
8. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–1540. [PubMed] [Google Scholar]
9. [Accessed September 19, 2010];US Preventive Services Task Force’s Guidelines for Early Detection of Cancer. //www.uspreventiveservicestaskforce.org/uspstopics.htm.
10. [Accessed September 19, 2010];American Cancer Society Guidelines for Early Detection of Cancer. //www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.
11. Welch GH. Maybe Not and Here’s Why. University of California Press; Berkeley: 2004. Should I Be Tested for Cancer? [Google Scholar]
12. National Cancer Institute [Accessed September 19, 2010];SEER-Medicare: Medicare enrollment and claims data. //www.healthservices.cancer.gov/seermedicare/medicare.
13. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40((8)(suppl)):IV-3–IV-18. [PubMed] [Google Scholar]
14. AJCC Cancer Staging Manual. 6th ed Springer; New York, NY: 2002. [Google Scholar]
15. SEER Program [Accessed September 19, 2010];Localized/regional/distant stage adjustments. //seer.cancer.gov/seerstat/variables/seer/yr1973_2004/lrd_stage/
16. International Classification of Diseases [Accessed September 19, 2010];Ninth Revision. //www.icd9data.com/
17. CPT Standard Edition: Current Procedural Terminology. American Medical Association Press; Chicago, IL: 2007. [Google Scholar]
18. Groman R, Ginsburg J, American College of Physicians Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004;141(3):226–232. [PubMed] [Google Scholar]
19. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575–584. [PubMed] [Google Scholar]
20. Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317–1324. [PubMed] [Google Scholar]
21. Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291(24):2990–2993. [PubMed] [Google Scholar]
22. Keating NL, Landrum MB, Rogers SO, Jr, et al. Physician factors associated with discussions about end-of-life care. Cancer. 2010;116(4):998–1006. [PMC free article] [PubMed] [Google Scholar]
23. Back AL, Arnold RM. Dealing with conflict in caring for the seriously ill: “it was just out of the question” JAMA. 2005;293(11):1374–1381. [PubMed] [Google Scholar]
24. Rousseau P. Death denial. J Clin Oncol. 2000;18(23):3998–3999. [PubMed] [Google Scholar]
25. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303(2):164–165. [PubMed] [Google Scholar]
26. Welch HG. Overdiagnosis and mammography screening. BMJ. 2009;339:b1425. [PubMed] [Google Scholar]
27. Schwartz LM, Woloshin S, Fowler FJ, Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71–78. [PubMed] [Google Scholar]
28. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685–1692. [PubMed] [Google Scholar]
29. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587. [PMC free article] [PubMed] [Google Scholar]
30. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–990. [PubMed] [Google Scholar]
31. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750–2756. [PubMed] [Google Scholar]
32. Iglehart JK. Finding money for health care reform: rooting out waste, fraud, and abuse. N Engl J Med. 2009;361(3):229–231. [PubMed] [Google Scholar]
33. Partridge AH, Winer EP. On mammography: more agreement than disagreement. N Engl J Med. 2009;361(26):2499–2501. [PubMed] [Google Scholar]
34. Truog RD. Screening mammography and the “r” word. N Engl J Med. 2009;361(26):2501–2503. [PubMed] [Google Scholar]
35. Grady D. [Accessed September 19, 2010];Quandary with mammograms: get a screening, or just skip it? New York Times. 2009 Nov 3; Second Opinion. //www.nytimes.com/2009/11/03/health/03second.html?_r=1.
36. Crewdson J. [Accessed September 19, 2010];Rethinking the mammogram guidelines. Atlantic. 2009 Nov 19; //www.theatlantic.com/magazine/archive/2009/11/rethinking-the-mammogram-guidelines/7791/
Page 2
Characteristics of Patients Diagnosed With Advanced Cancer Between 1998 and 2005 in One of the SEER Regionsa
Sex | |||||||
Male | 44 558 (51) | 29 063 (55) | 6214 (49) | 5797 (46) | 3484 (68) | 0 | 44 279 (51) |
Female | 43 178 (49) | 24 237 (45) | 6451 (51) | 6808 (54) | 1667 (32) | 4015 (100) | 43 028 (49) |
Age at diagnosis, y | 75 (70-80) | 75 (70-80) | 77 (71-82) | 76 (71-81) | 75 (70-80) | 76 (71-82) | 75 (70-80) |
Race/ethnicityb | |||||||
White | 71 440 (81) | 44 208 (83) | 10 137 (80) | 10 082 (80) | 3756 (73) | 3257 (81) | 71 423 (82) |
Black | 8125 (9) | 4699 (9) | 1291 (10) | 1141 (9) | 545 (11) | 449 (11) | 8053 (9) |
Hispanic | 3667 (4) | 1834 (3) | 586 (5) | 682 (5) | 379 (7) | 186 (5) | 3459 (4) |
Asian | 2689 (3) | 1560 (3) | 386 (3) | 406 (3) | 283 (5) | 54 (1) | 2631 (3) |
Other | 1815 (2) | 999 (2) | 265 (2) | 294 (2) | 188 (4) | 69 (2) | 1741 (2) |
Marital status | |||||||
Married | 45 942 (52) | 28 155 (53) | 6411 (51) | 7023 (56) | 3058 (59) | 1295 (32) | NA |
Not married or unknown | 41 794 (48) | 25 145 (47) | 6254 (49) | 5582 (44) | 2093 (41) | 2720 (68) | NA |
Year of diagnosis | |||||||
1998-1999 | 11 376 (13) | 6716 (13) | 1854 (15) | 1538 (12) | 714 (14) | 554 (14) | 11 283 (13) |
2000-2001 | 23 467 (27) | 14 184 (27) | 3447 (27) | 3290 (26) | 1387 (27) | 1159 (29) | 23 361 (27) |
2002-2003 | 26 139 (30) | 16 073 (30) | 3715 (29) | 3761 (30) | 1501 (29) | 1089 (27) | 26 040 (30) |
2004-2005 | 26 754 (30) | 16 327 (31) | 3649 (29) | 4016 (32) | 1549 (30) | 1213 (30) | 26 623 (30) |
Screening historyc | |||||||
Mammography | 9461 (26) | 5838 (26) | 1250 (21) | 1984 (32) | 389 (25) | NA | NA |
Papanicolaou test | 5219 (13) | 3026 (14) | 627 (11) | 1134 (18) | 207 (13) | 225 (6) | NA |
Prostate-specific antigen | 14 875 (37) | 9513 (36) | 1902 (34) | 2263 (43) | 1197 (39) | NA | NA |
Lower GI endoscopy | 2721 (4) | 1899 (4) | NA | 573 (5) | 169 (4) | 80 (2) | NA |
Cholesterol | 34 465 (43) | 20 929 (43) | 4529 (39) | 5782 (50) | 1993 (43) | 1232 (34) | NA |